A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 64 (1), 29-32
- https://doi.org/10.1016/s0167-8140(02)00104-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Parotid-Sparing Irradiation for Cancer of the Oral CavityAmerican Journal of Clinical Oncology, 2001
- Post-radiation severe xerostomia relieved by pilocarpine: a prospective French cooperative studyRadiotherapy and Oncology, 2000
- Preemptive Pharmacologic Intervention in Radiation-Induced Salivary DysfunctionProceedings of the Society for Experimental Biology and Medicine, 1999
- Acquired Salivary Dysfunction: Drugs and RadiationAnnals of the New York Academy of Sciences, 1998
- Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomiaInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Lent soma scales for all anatomic sitesInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck CancerThe New England Journal of Medicine, 1993
- A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.Journal of Clinical Oncology, 1993
- Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunctionCancer, 1993